ArticleLeukemia2025

Correspondence to: "Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations", Curik N et al. Leukemia. 2024; 38: 1415-1418.

Seiichi Okabe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.